Overview

• Kaiwa Technology in Guangzhou says it is developing a humanoid with an embedded artificial womb that uses synthetic amniotic fluid and an umbilical‑like tube for nutrient and oxygen delivery.
• Founder Zhang Qifeng presented the concept at the 2025 World Robot Conference in Beijing, with reports describing a late‑stage prototype and a planned retail price of about 100,000 yuan.
• The company has not disclosed any testing with human eggs, sperm, or embryos, and no peer reviewed studies or independent validations have been made public.
• Daily Galaxy cites claims of a public demonstration by 2026, which remain unverified and contingent on technical and regulatory progress.
• Kaiwa says it has submitted policy proposals to Guangdong authorities seeking a legal framework, while scientists highlight unresolved hurdles such as implantation and placental functions, noting only animal‑model precedents like the 2017 lamb ‘biobag’ study.